Tolterodine ๐
๐ Tolterodine is used for urge incontinence rather than stress incontinence.
It may be tried as a short course in patients with urge or mixed urge/stress symptoms.
๐ About
Always check the BNF link here for up-to-date prescribing advice.
- Antimuscarinic drug, related to oxybutynin but often better tolerated.
- Acts on bladder smooth muscle to reduce detrusor overactivity.
โ๏ธ Mechanism of Action
- Competitive muscarinic acetylcholine receptor antagonist.
- Reduces involuntary bladder contractions.
- Increases bladder capacity and delays urgency.
๐ฏ Indications
- Urinary frequency, urgency, and urge incontinence ๐ป.
- Mixed stress/urge incontinence (as part of trial therapy).
- Reduces detrusor instability and improves bladder storage.
๐ Interactions
- Avoid co-prescribing with other antimuscarinics (e.g. tricyclic antidepressants).
- Ketoconazole and other CYP3A4 inhibitors may โ tolterodine concentrations.
โ Contraindications / Cautions
- โ ๏ธ Narrow-angle glaucoma (risk of acute angle closure).
- โ ๏ธ Myasthenia gravis.
- โ ๏ธ Congenital or acquired QT prolongation (risk of arrhythmia).
- Caution in elderly patients due to CNS side effects.
โ ๏ธ Side Effects
- Dry mouth, constipation, blurred vision ๐๏ธ.
- Urinary retention ๐ง.
- Tachycardia, palpitations โค๏ธ.
- Confusion, cognitive impairment, drowsiness ๐ง (particularly in elderly).
- Peripheral oedema.
๐ Dose
- Tolterodine 1โ2 mg twice daily (lower dose in elderly or frail patients).
- Modified-release preparation available for once-daily use.
๐ References